101 – 110 of 154
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
COPD and the risk of tuberculosis--a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Journal of Innate Immunity : Editors' choice
(
- Contribution to journal › Debate/Note/Editorial
- 2009
-
Mark
SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.
(
- Contribution to journal › Article
-
Mark
SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
(
- Contribution to journal › Article
-
Mark
Bacterial proteases disarming host defense
(
- Contribution to journal › Debate/Note/Editorial
- 2008
-
Mark
The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial
(
- Contribution to journal › Article
-
Mark
Antibacterial chemokines - actors in both innate and adaptive immunity.
(
- Contribution to journal › Article
-
Mark
Increased Prevalence of Multiple Sclerosis Among COPD Patients and Their First-Degree Relatives: A Population-based Study.
(
- Contribution to journal › Article
-
Mark
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD
(
- Contribution to journal › Article
- 2007
-
Mark
The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids
(
- Contribution to journal › Article